Clozapine re-challenge in patients with history of blood dyscrasia 3 Year follow up
Journal: University Journal of Medicine and Medical Specialities (Vol.4, No. 4)Publication Date: 2018-10-03
Authors : ALKA SINGH;
Page : 37-38
Keywords : Agranulocytosis; Clozapine re-challenge; Filgrastim;
Abstract
Clozapine re-challenge in an individual with a history of clozapine-induced blood dyscrasia is not often attempted. However it can be considered in patients with history of good response to the drug in the past, and where the risk of re-challenge is considered to be less than the risk of withholding treatment. Increasing the frequency of monitoring of white blood counts and the use of lithium or Granulocyte-Colony Stimulating Factors are the strategies that have been reported to be helpful during re-challenge. A dyscrasia that occurs during rechallenge is reported to be earlier in onset and longer lasting. We report the three year follow up data of two patients who had a blood dyscrasia following which they were re-challenged with clozapine
Other Latest Articles
- COMPARISON AND ANALYSIS OF CLINICAL PROFILE AND TREATMENT OUTCOME IN ELDERLY TB PATIENTS IN URBAN AND RURAL AREAS OF TAMILNADU -IMPLICATIONS IN MANAGEMENT
- A Study on Prevalence of Loneliness and its association with health problems among elderly in Chennai-2015
- A cross sectional study to assess the factors affecting the compliance to Anti-Tuberculosis treatment among defaulters under DOTS in Villupuram, Tamil Nadu 2015
- Clinical profile of anti Ku autoantibody a cohort study from a tertiary care centre in South India
- Challenges in High Level Amputation of Lower Limbs due to Tumours in Adolescent Patients
Last modified: 2018-10-08 15:06:09